An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Dr. Ritzzel discusses the efficacy of Glar300 in individuals inadequately controlled on GLP-1 RA. This engaging talk provides a deep understanding of how Glar300 can enhance diabetes management and improve patient outcomes. Don’t miss out on this opportunity to enhance your understanding and improve patient outcomes.